CMMB   $1.57  -4.27% Market Closed After Close 1.57 0.0

Chemomab Therapeutics Ltd
Total Cash 12.73M
totalCashPerShare 0.044
EBITDA -15.97M
Total Debt 360.00K
quickRatio 3.106
currentRatio 3.123
Total Revenue
debtToEquity 3.605
Revenue/Share
ROA -0.4618
ROE -0.93802
grossProfits
freeCashflow -11.36M
operatingCashflow -16.13M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 399.74M
forwardPE -35.75
floatShares 169.53M
sharesOutstanding 18.86M
sharesShort 93.59K
sharesShortPriorMonth 58.58K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.12%
heldPercentInstitutions 0.27%
Short Ratio help_outline 0.59%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 0.695
Price To Book help_outline 2.06
earningsQuarterlyGrowth
netIncomeToCommon -15.00M
trailingEps -1.06%
forwardEps -0.04%
enterpriseToEbitda -25.03
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.01 3Q 2024
institutionsCount 18
lastUpdated Nov. 7, 2024, 4:58 a.m.